Esperion Therapeutics
ESPR
#8322
Rank
NZ$0.29 B
Marketcap
$1.47
Share price
-7.15%
Change (1 day)
-58.97%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2023 (TTM): -$4.63

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.71. In 2022 the company made an earnings per share (EPS) of -$5.93 an increase over its 2021 EPS that were of -$15.97.

EPS history for Esperion Therapeutics from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.63-22%
2022-$5.93-62.87%
2021-$15.9780.38%
2020-$8.8550.14%
2019-$5.90-53.18%
2018-$12.607.41%
2017-$11.73110.81%
2016-$5.5647.35%
2015-$3.780.89%
2014-$3.7428.84%
2013-$2.90-89.3%
2012-$27.15
2002-$11.448.89%
2001-$10.50-83.77%
2000-$64.73

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$17.11 263.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.30-127.61%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.11-165.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$62.41-1,424.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.07-77.30%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.14-75.89%๐Ÿ‡บ๐Ÿ‡ธ USA